Search Results

This in vitro method is intended to quantitatively measure the antiepileptic drug valproic acid in human serum and plasma on the Bayer ADVIA® IMS systems. Measurements of valproic acid are used to aid in monitoring therapeutic levels of valproic acid to ensure appropriate therapy and in the treatment of valproic acid overdose.
The Bayer ADVIA IMS Valproic Acid method is for in vitro diagnostic use to measure the antiepileptic drug valproic acid in human serum and plasma. Measurements of valproic acid (2-propylpentanoic acid) are used as an aid in the diagnosis and treatment of valproic acid overdose, and in monitoring therapeutic levels of valproic acid to ensure appropriate therapy.

Not Found

1. Acceptance Criteria and Reported Device Performance

Study Proving Acceptance Criteria:

The provided document describes a validation study comparing the performance of the ADVIA® IMS Valproic Acid Method to a predicate device, the Bayer Centaur Valproic Acid method. The study design is a comparative effectiveness study demonstrating substantial equivalence rather than explicitly listing acceptance criteria targets. The "acceptance criteria" are implied by showing performance that is either equivalent or superior to the legally marketed predicate device across various metrics.

2. Sample Size Used for the Test Set and Data Provenance:

• Sample Size for Test Set:
  • Correlation Study: N = 50 (specimens)
  • Minimum Detectable Concentration: Multiple measurements to determine the detection limit.
  • Imprecision: Not explicitly stated as a number of patient samples, but "Level" indicates control or spiked samples were likely run repeatedly.
  • Interfering Substances: Not explicitly stated as a number of patient samples, but specific concentrations of interferents were used with a valproic acid concentration.
• Data Provenance: Not explicitly stated in the provided text. It is a submission by Bayer Corporation, so the data is likely generated in a regulated environment for a diagnostic product. The document does not specify the country of origin of the data or whether it was retrospective or prospective.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications of those Experts:

This is a study for an in vitro diagnostic (IVD) device that measures a chemical analyte (valproic acid) quantitatively. The "ground truth" for such devices is established by reference methods or established analytical techniques, often using certified reference materials or highly accurate comparative methods.

• Experts: Not applicable in the sense of clinical experts interpreting images or patient conditions. The "ground truth" is analytical.
• Qualifications: The "expert" in this context is the predicate device and its established analytical performance. The comparison system (Centaur) acts as the reference for determining correlation.

4. Adjudication Method for the Test Set:

Not applicable. Adjudication methods (e.g., 2+1, 3+1) are typically used in clinical studies where human interpretation of ambiguous data (like medical images) requires consensus among experts. For a quantitative IVD device like this, the "data" are numerical results, and the comparison is statistical.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study:

No, an MRMC study was not done. MRMC studies are used to evaluate human reader performance, often with and without AI assistance, in interpreting clinical cases (e.g., radiology images). This document describes the performance of an automated analytical method on an in vitro test, not a human interpretation task.

Effect Size: Not applicable, as no MRMC study was performed.

6. Standalone Performance Study:

Yes, a standalone performance study was done. The entire document describes the standalone performance of the ADVIA IMS Valproic Acid method in terms of its analytical characteristics (MDC, imprecision, correlation, interference, analytical range) when compared against or measured relative to a predicate device and known standards. The "algorithm" is the reagent and instrument system, and its performance is evaluated without human intervention in the measurement process itself. The readings produced by the device are the output being evaluated.

7. Type of Ground Truth Used:

The ground truth used for this quantitative measurement device is primarily:

• Comparison to a Legally Marketed Predicate Device (Centaur): For correlation studies, the results from the Centaur system serve as the comparative reference.
• Known Concentrations/Standards: For MDC, imprecision, and interference studies, presumably, samples with known, controlled valproic acid concentrations (e.g., spiked samples, control materials) were used.
• This falls under the category of analytical validation against established methods and reference materials, rather than pathology or complex outcomes data.

8. Sample Size for the Training Set:

The document does not provide information on a "training set" or its sample size. This is common for IVD devices that rely on established chemical reactions and optical/electrical detection rather than machine learning algorithms that require explicit training data. The "training" for such a system would involve optimizing reagent formulations and instrument calibration procedures, but not in the sense of a machine learning model.

9. How the Ground Truth for the Training Set Was Established:

As there is no mention of a "training set" in the context of machine learning, this question is not applicable. For a traditional IVD device, the "ground truth" for establishing methods and calibrating instruments would be based on:

• Reference Methods: Using highly accurate and validated analytical techniques to assign values to calibrators and controls.
• Certified Reference Materials: Using materials whose valproic acid concentrations are traceable to international standards.
• Method Development and Optimization: The design and chemical properties of the reagents, along with instrument parameters, are developed based on known chemical principles and extensive testing during the R&D phase to ensure accurate measurement across the analytical range.

Ask a specific question about this device